Cited by

• A Machine Learning-Based Mortality Prediction Model for Patients with Chronic Hepatitis C Infection: An Exploratory Study.

  Al Alawi AM, Al Shuaili HH, Al-Naamani K, Al Naamani Z, Al-Busafi SA. Al Alawi AM, et al. J Clin Med. 2024 May 16;13(10):2939. doi: 10.3390/jcm13102939. J Clin Med. 2024. PMID: 38792479 Free PMC article.
• Predictors of survival among patients with chronic hepatitis C at a tertiary care center in Oman.

  Al-Shuaili HH, Al-Busafi SA, Al-Naamani K, Al-Naamani Z. Al-Shuaili HH, et al. Saudi J Gastroenterol. 2024 Jan 1;30(1):45-52. doi: 10.4103/sjg.sjg_201_23. Epub 2023 Sep 20. Saudi J Gastroenterol. 2024. PMID: 38190454 Free PMC article.
• Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection.

  Wranke A, Heidrich B, Deterding K, Hupa-Breier KL, Kirschner J, Bremer B, Cornberg M, Wedemeyer H. Wranke A, et al. Hepatol Int. 2023 Dec;17(6):1359-1367. doi: 10.1007/s12072-023-10575-0. Epub 2023 Oct 3. Hepatol Int. 2023. PMID: 37789170 Free PMC article.
• Unmet Needs in the Post-Direct-Acting Antiviral Era: Hepatocarcinogenesis After Hepatitis C Virus Eradication.

  Przybyszewski EM, Chung RT. Przybyszewski EM, et al. J Infect Dis. 2023 Sep 13;228(Suppl 3):S226-S231. doi: 10.1093/infdis/jiac447. J Infect Dis. 2023. PMID: 37703341 Free PMC article.
• Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study.

  Hamill V, Wong S, Benselin J, Krajden M, Hayes PC, Mutimer D, Yu A, Dillon JF, Gelson W, Velásquez García HA, Yeung A, Johnson P, Barclay ST, Alvarez M, Toyoda H, Agarwal K, Fraser A, Bartlett S, Aldersley M, Bathgate A, Binka M, Richardson P, Morling JR, Ryder SD, MacDonald D, Hutchinson S, Barnes E, Guha IN, Irving WL, Janjua NZ, Innes H. Hamill V, et al. BMJ. 2023 Aug 2;382:e074001. doi: 10.1136/bmj-2022-074001. BMJ. 2023. PMID: 37532284 Free PMC article.